accessibility menu, dialog, popup

UserName
Viewing profile as user:

Bromobenzenes

Organic compounds considered aryl halides that consist of a phenyl group with a bromine atom substitution in the following structure: C₆H₅Br.
Molecular Weight (g/mol) 
  • (2)
Percent Purity 
  • (2)
Physical Form 
  • (2)
Quantity 
  • (1)
  • (1)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (4)
  • (2)
  • (4)

special interests

  • (4)

Molecular Weight (g/mol)

  • (2)

Percent Purity

  • (2)

Physical Form

  • (2)

Quantity

  • (1)
  • (1)

Search Within Results
Keyword Search:
1 – 9 of 9 results
1

2-(4-Bromophenyl)-4,6-diphenyl-1,3,5-triazine 98.0+%, TCI America™

CAS: 23449-08-3 Molecular Formula: C21H14BrN3 Molecular Weight (g/mol): 388.27 MDL Number: MFCD00194632 InChI Key: AYHGAQGOMUQMTR-UHFFFAOYSA-N PubChem CID: 1728672 IUPAC Name: 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine SMILES: BrC1=CC=C(C=C1)C1=NC(=NC(=N1)C1=CC=CC=C1)C1=CC=CC=C1

PubChem CID 1728672
CAS 23449-08-3
Molecular Weight (g/mol) 388.27
MDL Number MFCD00194632
SMILES BrC1=CC=C(C=C1)C1=NC(=NC(=N1)C1=CC=CC=C1)C1=CC=CC=C1
IUPAC Name 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine
InChI Key AYHGAQGOMUQMTR-UHFFFAOYSA-N
Molecular Formula C21H14BrN3
2

Medchemexpress LLC EP2 receptor antagonist-1 | 848920-08-1 | 99.8% | C24H22N4O5 | 50 MG
SDP

EP2 receptor antagonist-1 (compound 1) is a potent, reversible, and agonist-dependent allosteric prostaglandin EP2 receptor antagonist that demonstrates anti-inflammatory effects. It is intended for research use only and presents as an off-white to light yellow solid with a molecular weight of 446.46.

  • Soluble in DMSO at 100 mg/mL for in vitro use
  • Should be shipped at room temperature in the continental US
  • Store as powder at -20°C for 3 years or 4°C for 2 years
  • In solution, store at -80°C for 6 months or -20°C for 1 month

ENCOMPASS_PREFERRED
3

Medchemexpress LLC EP2 receptor antagonist-1 | 848920-08-1 | 99.8% | C24H22N4O5 | 100 MG
SDP

EP2 receptor antagonist-1 (compound 1) is described as a potent, reversible, and agonist-dependent allosteric prostaglandin EP2 receptor antagonist. It demonstrates anti-inflammatory effects and is intended for research use only.

  • Potent, reversible, and agonist-dependent allosteric EP2 receptor antagonist
  • Exhibits anti-inflammatory effects
  • Target: EP2
  • For research use only

ENCOMPASS_PREFERRED
4

Medchemexpress LLC EP2 receptor antagonist-1 | 848920-08-1 | MFCD32708541 | 99.8% | C24H22N4O5 | 10MG
SDP

EP2 receptor antagonist-1 is a potent, reversible, agonist-dependent allosteric antagonist of the prostaglandin EP2 receptor. It is provided as a research-grade small molecule for in vitro and in vivo pharmacology studies and has reported anti-inflammatory activity.

  • Allosteric, agonist-dependent EP2 receptor antagonist.
  • Reversible binding profile suitable for pharmacology studies.
  • Reported anti-inflammatory activity in preclinical models.
  • High reported purity (≈99.8%).
  • Molecular formula C24H22N4O5; molecular weight ≈446.5 g/mol.
  • Storage: powder -20°C for long-term; limited solvent stability.
  • Supplied in research-scale quantities for laboratory use.

ENCOMPASS_PREFERRED
5

Medchemexpress LLC Ep2 receptor antagonist-1 | 848920-08-1 | 99.8% | 446.46 g/mol | C24H22N4O5 | 5 MG
SDP

EP2 receptor antagonist-1 is a small-molecule research compound described as a potent, reversible, agonist-dependent allosteric antagonist of the prostaglandin EP2 receptor. It is provided as a high-purity solid or solution for in vitro and pharmacological studies, with documented stability and supporting analytical documentation.

  • Potent, reversible, agonist-dependent allosteric antagonist of the prostaglandin EP2 receptor.
  • High purity (reported 99.84%).
  • Chemical formula C24H22N4O5; molecular weight 446.46 g/mol.
  • Available as solid and as solution formats for flexibility in assays.
  • Documented storage stability for powder and in-solution conditions.
  • SMILES and analytical data provided in supporting documents.

ENCOMPASS_PREFERRED
6

eMolecules​ 1-(4-Bromophenyl)-4-methylpiperazine | 130307-08-3 | MFCD09029689 | 1g

Combi-Blocks | 1-(4-Bromophenyl)-4-methylpiperazine | 1g | 117518548 | AM-1729 | 98.000 | 130307-08-3 | MFCD09029689 | 255.159 | C11H15BrN2

If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool

ENCOMPASS_PREFERRED
7

eMolecules​ (1R)-1-(3-Bromophenyl)-N-methyl-ethanamine hydrochloride | 2366997-08-0 | | 1g

Apollo Scientific | (1R)-1-(3-Bromophenyl)-N-methyl-ethanamine hydrochloride | 1g | 562429814 | OR475155 | | 2366997-08-0 | | 250.560 | C9H13BrClN

If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool

ENCOMPASS_PREFERRED
8

eMolecules​ N-[(1S)-1-(3-Bromophenyl)ethyl]cyclopropanamine hydrochloride | 2407348-08-5 | | 1g

Apollo Scientific | N-[(1S)-1-(3-Bromophenyl)ethyl]cyclopropanamine hydrochloride | 1g | 562460155 | OR475070 | | 2407348-08-5 | | 276.600 | C11H15BrClN

If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool

ENCOMPASS_PREFERRED
9

eMolecules​ ChemScene / 4-Bromo-1-(3-bromophenyl)-1H-pyrazole / 100mg / 712788530 / CS-0432860 / 0.000 / 1363254-08-3 / MFCD21642123 / 301.969 / C9H6Br2N2

ChemScene / 4-Bromo-1-(3-bromophenyl)-1H-pyrazole / 100mg / 712788530 / CS-0432860 / 0.000 / 1363254-08-3 / MFCD21642123 / 301.969 / C9H6Br2N2

ENCOMPASS_PREFERRED